Cardiac arrest victims who receive coronary angiography are twice as likely to survive without significant brain damage compared with those who don't have the imaging procedure, according to a new ...

Assessing intermediate coronary lesions with an intracoronary pressure wire improves clinical outcomes in patients undergoing cardiac catheterization and percutaneous coronary intervention (PCI).

Cardiac CT angiography (CCTA) is increasingly being used to diagnose coronary artery disease; however, radiation exposure carries risks, which increase with repeated scans. Now a study of worldwide ...

In an analysis of Medicare data of nearly 300,000 patients who underwent outpatient evaluation for coronary artery disease by either computed tomography (CT) angiography or stress testing, those who ...

Using artificial intelligence (AI) to analyze electrocardiograms (ECG) improved detection of severe heart attacks, including those that presented with unconventional symptoms, or atypical ECG patterns ...

A speedy trip to the cath lab for coronary angiography is not linked to better outcomes in patients who suffer an out-of-hospital cardiac arrest but do not have ST-segment elevation on an initial ECG, ...

Coronary angiography could wait among people successfully resuscitated from cardiac arrest in the absence of ST-segment elevation MI (STEMI), longer-term results from the COACT trial confirmed.

After cardiac arrest, certain patients with suspected ST-segment elevation myocardial infarction (STEMI) are denied emergent angiography due to adverse clinical factors or the judgment that ...

PHOENIX (May 20, 2023) – Today, the Society for Cardiovascular Angiography & Interventions (SCAI) announced its 2023 Master Interventionalists of SCAI (MSCAI) designation recipients during the SCAI ...

A peripheral angiogram is a test that checks for blockages in the arteries that supply blood to your legs and feet or your arms and hands. These arteries are called peripheral arteries because they ...

According to iData's U.S. Market Report Suite for Interventional Cardiology, the market was valued at $3.9 billion in 2022. This is expected to increase over the forecast period to reach approximately ...